[1]
Ma, Z. and Zhang, Y. 2025. TPM-1: A Novel Biomaterial for Cancer Immunotherapy Targeting PD-L1. MedScien. 3, 4 (Aug. 2025), 4252. DOI:https://doi.org/10.61173/nwxhsh58.